Literature DB >> 31345528

Calcium Metabolic Disorders in Pregnancy: Primary Hyperparathyroidism, Pregnancy-Induced Osteoporosis, and Vitamin D Deficiency in Pregnancy.

Julius Simoni Leere1, Peter Vestergaard2.   

Abstract

Physiologic changes during pregnancy include calcium, phosphate, and calciotropic hormone status. Calcium metabolic disorders are rare in pregnancy and management with close calcium and vitamin D control and supplementation. Primary hyperparathyroidism is mostly asymptomatic and does not affect conception or pregnancy. It requires control of plasma calcium levels. Surgical intervention may be indicated. Data on severe cases are missing. Osteoporosis in or before pregnancy is rare but usually diagnosed from fractures. Medical treatment other than supplementation is contraindicated. Vitamin D deficiency is common and may affect conception and increase complications. Current evidence does not prove vitamin D supplements effective in improving outcomes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcium metabolism; Hypoparathyroidism; Osteoporosis; Pregnancy; Primary hyperparathyroidism; Vitamin D

Mesh:

Substances:

Year:  2019        PMID: 31345528     DOI: 10.1016/j.ecl.2019.05.007

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  3 in total

Review 1.  Bone metabolism and osteoporosis during pregnancy and lactation.

Authors:  Abraham Yair Lujano-Negrete; Martha Cecilia Rodríguez-Ruiz; Cassandra Michele Skinner-Taylor; Lorena Perez-Barbosa; Jesus Alberto Cardenas de la Garza; Pedro Alberto García-Hernández; Luis Gerardo Espinosa-Banuelos; Luz Fernanda Gutierrez-Leal; Sofia Jezzini-Martínez; Dionicio Ángel Galarza-Delgado
Journal:  Arch Osteoporos       Date:  2022-02-19       Impact factor: 2.617

Review 2.  Parathyroid Disease in Pregnancy and Lactation: A Narrative Review of the Literature.

Authors:  Elena Tsourdi; Athanasios D Anastasilakis
Journal:  Biomedicines       Date:  2021-04-26

3.  Inhibition of lung cancer by vitamin D depends on downregulation of histidine-rich calcium-binding protein.

Authors:  Ning Liu; Xiaofeng Li; Yu Fu; Ye Li; Wanyi Lu; Yiming Pan; Jingxin Yang; Juan Kong
Journal:  J Adv Res       Date:  2020-08-27       Impact factor: 10.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.